The management of head and neck cancer in recent years has involved increasingly
complex, combined-modality programs, as well as the integration of new diagnostic and …

Three decades of collaborative research have led to the integration of platinum‐based
chemotherapy into the curative management of squamous cell carcinoma of the head and …

The management of squamous cell carcinoma of the head and neck (HNSCC) has been the
focus of extensive clinical research during the last 20 years [1]. Traditionally, options for …

Chemotherapy, when combined with radiotherapy and/or surgery in the treatment of patients
with head and neck cancer, appears to be most efficacious if it is given concurrently with …

Head and neck cancer is estimated to be one of the most prevalent cancers in the world.
This tumour type accounts for 5% of all new cancer cases in the US and Europe each year …

CA advanced squamous cell carcinoma of the upper aerodigestive tract. We have some
evidence that use of chemotherapy at the time of definitive treatment may delay the …

Leading expert physicians and investigators from around the world review the state-of-the-
art in the management of squamous cell head and neck cancer, with emphasis on …

Treatment of advanced squamous cell cancers of the head and neck (HNSCC) can be a
frustrating endeavor. Early diagnosis may be missed by delay on the part of patients or their …

Head and neck cancer represents $5% of all cancers and> 500000 new cases are
diagnosed worldwide each year. Approximately 60–65% of patients with head and neck …

Head and neck cancer is the eighth most common cause of cancer death worldwide. Its
incidence varies widely among different regions. In North America and the European Union …